EAM

Exome Asset Management Portfolio holdings

AUM $202M
1-Year Est. Return 151.75%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+151.75%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$148M
AUM Growth
+$35.6M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
82
New
Increased
Reduced
Closed

Top Buys

1
+$4.65M
2
+$4.41M
3
+$4.12M
4
GILD icon
Gilead Sciences
GILD
+$3.82M
5
SWTX
SpringWorks Therapeutics
SWTX
+$3.76M

Top Sells

1
+$5.2M
2
+$3.84M
3
+$3.64M
4
ONC
BeOne Medicines Ltd
ONC
+$3.22M
5
MDGL icon
Madrigal Pharmaceuticals
MDGL
+$3.03M

Sector Composition

1 Healthcare 98.79%
2 Financials 0.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
76
– –
-45,100
77
– –
-358,400
78
– –
-50,700
79
– –
-32,900
80
– –
-443,379
81
– –
-488,135
1 2 3
4